Christian Soschner
Beginner's Mind
Blueprints for Builders and Investors Hosted by Christian Soschner From pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech —lives or dies by the frameworks it follows. On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds. With over 250 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast....
Be sure to visit the podcast's website and support the creator: www.linkedin.com
Author
Christian Soschner
Category
Podcast website
Latest episode
Nov 1, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
#81: Astrid Woollard and Christian Niedermüller - The Future of Investments in Digital Assets 25.07.2022 1:29:12
What is happening in all things digital assets, cryptocurrencies, NFTs, and alike? The market crashed. Is it all over now? Investing with experts is always the best idea when investing in new areas. This episode was recorded in February 2022, and I am happy that I had the chance to speak with two experts in digital assets from Austria: Astrid Woollard and Christian Niedermüller , SMAPE Capital As...
#80: Alexander Belcredi and Lorenzo Corsini - How to Create An Overnight Success As An Entrepreneur 12.07.2022 1:37:03
It is the 80th episode on my podcast channel. In 2020 I wanted to try how podcasts can bring value to my life science business community. One of the first speakers on the podcast was Alexander Belcredi, Phagomed. He and Co-CEO Lorenzo Corsini started their Company in 2015 and developed Alternatives to Antibiotics.; which was also the title of Episode #9 - Alternatives to Antibiotics. In April 2020...
#79: Jonathan Sporn - How Psychedelic Drugs Help Ease the Mental Health Burden in Society 28.06.2022 1:58:17
These days many sources are highlighting the shocking scale of the global mental health crisis and how this affects approx—a staggering one billion people worldwide - over one-seventh of the global population. “Unfortunately, as harrowing and monstrous this number is”, the investor Christian Angermayer wrote in a blog post, “it is my belief this is a gross UNDER-estimate.” Ultimately, the number o...
#78: Gerda Redl - The Future of Life Science Patents 09.06.2022 1:31:51
Warren Buffett recommends buying companies with a great moat. Something that makes the company unique and protects the business from the competition. Patents are the best moats. Do you want to know why? Then listen to Gerda Redl. Who is the speaker? Dr. Gerda Redl is a patent attorney with more than 20 years of experience in the life sciences industry. Her technical expertise is in biotechnology,...
#77: Alexander Valtingojer - How to Invest in Digital Assets 01.06.2022 1:53:23
What is going on in the world of digital assets in 2022? In May 2010, 10,000 BTC bought 2 Pizza. Last year in November, the same amount had a value of 600 Million dollars. A lot has evolved since 2010 in the digital asset ecosystem. That's why I asked Alexander Valtingojer , CEO of Coinpanion , to discuss the latest development in the crypto market. This episode was recorded in January 2022....
#76: Rich Masters - How the Pandemic Changed the Conference Industry - Bio US 2022 in San Diego 22.05.2022 1:02:37
How Did the Conference Industry Change in the last two years? Philadelphia in 2019 was the last Bio I attended in person. In March 2020, the world shut down to respond to the novel viral threat. Since then, all conferences have been digital. What effect did this have on the conference Industry – especially the Bio US ? Listen to Rich Masters , Chief Public Affairs and Marketing Officer of Bio....
#75: Lisa Stöger - Creating Connections Between StartUps and International Stakeholders 17.05.2022 1:12:52
Are you interested to expand your business into Asian Markets? Then this episode might be for you. As Program Manager of the Global Incubator Network Austria (GIN) , Lisa Stöger has successfully connected the Austrian startup ecosystem with the world's most innovative startup hubs for the last 4 years. With a focus on Asian markets, she supports Austrian startups in their internationalizatio...
#74: Mark Herschberg - Why Networking and Leadership are Important Skills for Deeptech Entrepreneurs 10.05.2022 1:23:18
Do you want to know why networking and leadership are so important to be successful in business? And why everybody, including employees, needs to learn those skills? Then this episode is for you. Mark is the author of The Career Toolkit, Essential Skills for Success That No One Taught You. Educated at MIT, Mark has spent his career launching and fixing new ventures at startups, Fortune 500s, and...
#73: Bharat Kanodia - How to Value Unique Assets 29.04.2022 53:00
Do you want to know how to value a company and what Julia Roberts has to do with it? Then listen to Bharat Kanodia in this episode number 73. Valuation is one of the most difficult exercises in the startup world. How can you put a price tag on a company that doesn’t exist yet? Get help from an expert: Bharat Kanodia has valued over 2000 businesses and signed off on assets worth $2.6 trillion in v...
#72: Stefan Sandström - How to do Business in Japan 14.04.2022 1:09:21
Do you want to reach out to Japanese companies and universities? Then you should know what makes Japan special and different to have a smooth business experience. Different Cultures – Different Rules and Different ways to success Japan is the second biggest market for pharmaceuticals globally. The area is not only interesting for its sales potential; it is also a major R&D hub in Asia. One of...
#71: Heike Schoen - How To Rescue Your Clinical Trial When at Risk to Fail 28.03.2022 1:39:25
Did you know that almost 90% of all product ideas fail in clinical trials? Surprising to me was that lack of efficacy doesn't seem to be the main reason why clinical trials fail in the first place. Other factors are at play, and most of them are manageable risks when the right team is at work. In this episode: Strategic considerations for setting up a clinical trial Inhouse vs Outsourced Cli...
#70: Bruno Montanari - How Venture Capital Supports Science And Innovation 13.03.2022 1:42:28
Big corporations strive to bring new solutions to their customers to help them solve their most pressing problems. To do so the corporation needs to be innovative. That's why companies like Apple, Google, Pfizer, and similar players want to cooperate with start-ups and scale-ups globally. Such cooperations strive to collaborate with top startups, invest in them, and sometimes acquire them to...
#69: Prof. Collin Ewald - Molecular Mechanisms of Healthy Ageing 26.02.2022 1:32:27
Lately, investors and researchers have published more and more information on longevity research and development. Investors like Sergey Young or Christian Angermayer started to bet significant capital on this topic. What is going on in this field on the research side? What are potential applications to increase the Lifespan? And when will those innovations hit the market? In this episode, I had a...
#68: Mauricio Agudelo and Lina María Toro - Sustainable Animal Nutrition 15.02.2022 1:12:54
What significant problems does the food industry face today? Which solutions are already in development? In this episode, I am talking with Mauricio Agudelo and Lina María Toro about Sustainable Food Innovation in South America. BIALTEC assists animal protein producers to improve productivity and profitability through precision nutrition, understanding their particular dietary needs, analyzing the...
#67: Kai Lamottke - Bringing Innovation to Life Science From China & Europe 06.02.2022 1:23:10
Innovation needs collaboration on a global scale. Making things happen requires entrepreneurs who love science and work day and night to connect the best minds globally and support them to translate their science into products and businesses. In this episode, I have a conversation with Kai Lamottke, CEO and Co-Founder of Bicoll . Dr. Kai Lamottke is co-founder & CEO of Bicoll GmbH and Bicoll B...
#66 - Martin Popilka, Denis Roio - This was 2021 - A year in Review 7/7 01.02.2022 59:46
Part 7 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Formula 1 Fuels Hand Sanitization Open Source and Technology I hope you enjoy the conversation the same way I did. Who are the Experts in thi...
#65 - Paul Polterauer, Philipp Peinsold, Markus Raunig - This was 2021 - A year in Review 6/7 26.01.2022 54:20
Part 6 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about NFTs Metaverse NanoMetaGames Austrian Entrepreneurship Week From Morning Moonshots to Future Weekly Apple & Spotify Podcast Algorithms I...
#64: Walter Stockinger, Yoni Falkson - This was 2021 - A Year in Review Part 5/7 19.01.2022 1:03:00
Part 5 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about The Effects of the Pandemic on Business Life The Future of ADCs in Oncology Mental Health Psychedelic Drug Development Gilgamesh Pharmaceutic...
#63: Albert Missbichler, Peter Llewellyn-Davies - This was 2021 - A Year in Review Part 4/7 16.01.2022 1:04:04
Part 4 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Biotech in Austria Culture of Success Business Angels, Investment and Market Perspective Customer Needs and Entrepreneurship I hope you enjoy...
#62: Christian Soschner, Johannes Sarx, Philipp Hainzl, Stefanie Rösel, Julia Resch - This was 2021 - A Year in Review Part 3/7 12.01.2022 1:17:58
Part 3 of the Year in Review Recording. 1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Content Marketing with a Podcast Life Science Industry in Austria Content Marketing and Social Media for B2B Businesses History of the Vien...
#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7 08.01.2022 1:20:42
Part 2 of the Year in Review Recording. 1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Health Literacy and the Healthcare System Venture Capital in 2021 Digitalization in Drug Development The Golden Age of Biotech Home Office...
#60: Astrid Woollard, Dusica Lukac, Matthias Tarasiewicz, Irénée Robin - This was 2021 - A Year in Review Part 1/7 02.01.2022 1:16:51
This is Part 1 of the 7,5 hours conversations marathon before Christmas with speakers from previous podcast episodes and business partners of the host and co-host of the Podcast. In this episode, we talk about Covid19 Cryptocurrencies Cybersecurity and Merger & Acquisition I hope you enjoy the conversation the same way as I did. Who are the Experts in this episode: Astrid Woollard Dusica Luka...
#59: Sascha Berger - TVM Capital - A Perspective on The Life-Science-Eco-System in the US and Europe 26.12.2021 39:24
In this episode, I am having a conversation with Sascha Berger , Partner at TVM Capital . Dr. Sascha Berger is a Partner at TVM Capital, based in Munich, Germany. TVM Capital is one of the pioneer transatlantic Life Science Venture Capital funds with Europe and North America teams. Sascha joined TVM Capital in 2016, helped raise the current $480M fund, and works closely with entrepreneurs and foun...
#58: Bettina Resl - Trends in the Pharma Industry in the 21st Century 21.12.2021 1:22:48
In this episode, I am having a conversation with Bettina Resl, Public Affairs Head Europe Consumer Healthcare at Sanofi. Bettina Resl joined Sanofi Austria in May 2017 as Country Head Public Affairs & Patient Advocacy. From April 2020 to June 2021 she was also responsible for corporate communications and finally took over the position of Public Affairs Head Europe Consumer Healthcare at Sanofi...
#57: Jaromír Zahrádka - Bridging Science and Business in the European Life Science Eco-System 12.12.2021 1:28:40
In this episode, I have a conversation with Jaromir Zahradka and we will talk about early-stage investments in DeepTech Life Science companies. He has 5+ years of C-level experience and has been engaged in 8 Biotech spin-offs. He built a unique network within CE institutions and TTOs and has deep scientific and licensing market expertise with over 20 licensing deals worth more than USD 500m. Ja...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.